Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Marek Dziki"'
Autor:
Waldemar A. Turski, M Kozicka, Zdzisław Kleinrok, Jolanta Parada-Turska, Czuczwar Sj, Rafal M. Kaminski, Marek Dziki
Publikováno v:
Pharmacological Research. 37:375-381
Prostaglandins and their inhibitors may affect convulsive phenomena. Thus, the aim of this study was to examine possible interactions between non-steroidal anti-inflammatory drugs and two conventional antiepileptic drugs in terms of their anticonvuls
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25f6580fdcd8f56db3e13ae5559ac133
https://doi.org/10.1006/phrs.1998.0309
https://doi.org/10.1006/phrs.1998.0309
Autor:
Grażyna Czechowska, Waldemar A. Turski, Stanisław J. Czuczwar, Marek Dziki, T. Pietrasiewicz, Zdzisław Kleinrok
Publikováno v:
European Journal of Pharmacology. 250:1-7
CGP 37849 (1 mg/kg i.p.) enhanced the protective action of carbamazepine, diphenylhydantoin and phenobarbital against maximal electroshock-induced convulsions in mice. At 0.25 mg/kg CGP 37849 was inactive and at 0.5 mg/kg it potentiated the anticonvu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23a0b1e57bcc32f50802a9ad1d1475b
https://doi.org/10.1016/0014-2999(93)90613-m
https://doi.org/10.1016/0014-2999(93)90613-m
Publikováno v:
European Journal of Pharmacology. 222:273-278
The effects of combined treatment with low doses (0.025-0.05 mg/kg i.p.) of the non-competitive NMDA receptor antagonist, MK-801 (dizocilpine), and the antiepileptic drug, valproate, were studied in amygdala-kindled and non-kindled rats. MK-801, 0.05
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5f43470f1c9c7730c57f0ba0e64f3f
https://doi.org/10.1016/0014-2999(92)90866-3
https://doi.org/10.1016/0014-2999(92)90866-3
Publikováno v:
Developmental Brain Research. 67:137-144
Immature rats are more susceptible to clonic seizures induced by aminooxyacetic acid (AOAA) than mature and senile rats. Highest susceptibility to AOAA seizures was observed in 7–14-day-old rat pups. The lowest susceptibility was recorded in 10–2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bd90e3b8b47faceb1603ae00d8d4aea
https://doi.org/10.1016/0165-3806(92)90214-h
https://doi.org/10.1016/0165-3806(92)90214-h
Autor:
Esper A. Cavalheiro, Marek Dziki, Lineu S. Calderazzo-Filho, Ewa M. Urbańska, Waldemar A. Turski
Publikováno v:
Synapse. 7:173-180
Systemic (s.c.) administration of aminooxyacetic acid (AOAA) in mice triggered clonic convulsions with a CD50 (convulsive dose) of 68 mg/kg (range 54-86). AOAA also induced clonic convulsions in mice subjected to intracerebroventricular administratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63cbab4e450894f718cac9d80feef939
https://doi.org/10.1002/syn.890070302
https://doi.org/10.1002/syn.890070302
Autor:
Waldemar A. Turski, Chrysanthy Ikonomidou, Ewa M. Urbańska, Jolanta Parada-Turska, Marek Dziki
Publikováno v:
Brain Research. 514:131-134
The effects of excitatory amino acid antagonists on convulsions induced by intracerebroventricular (i.c.v.) or systemic (s.c.) administration of the gamma-aminobutyric acidA (GABAA) antagonist bicuculline (BIC) were tested in mice. 3-[+/-)-2-Carboxyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d14229e09fac989e65f61f55ee42313c
https://doi.org/10.1016/0006-8993(90)90444-g
https://doi.org/10.1016/0006-8993(90)90444-g
Publikováno v:
Neuropharmacology. 31(10)
Memantine increased the threshold for electroconvulsions, when administered at 1.0–6.0 mg/kg (i.p.) and given in subthreshold dosesof 0.0156, 0.0625, 0.125 and 0.5 mg/kg (i.p.) potentiated the protective efficacy of valproate, against maximal elect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261d91dcf1f716a7e245bb8a675a6336
https://pubmed.ncbi.nlm.nih.gov/1436383
https://pubmed.ncbi.nlm.nih.gov/1436383
Publikováno v:
European journal of pharmacology. 200(2-3)
MK-801 (a potent non-competitive antagonist of N-methyl-D-aspartic acid-mediated events) in subcutanteous doses of 0.1 and 0.2 mg/kg increased the threshold for electroconvulsions and in doses of 0.0031 and 0.0125 mg/kg enhanced the protective activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b1071cf6a0ad9a2729fff99a1619f3
https://pubmed.ncbi.nlm.nih.gov/1782990
https://pubmed.ncbi.nlm.nih.gov/1782990